Ncs Multistage Hldgs Inc Stock Price, News & Analysis

NCS Multistage Holdings (Nasdaq: NCSM) reported Q3 2025 revenues of $46.5M, a 6% year-over-year increase, and net income of $3.8M ($1.37 diluted EPS). Adjusted EBITDA was $7.0M with a 15% margin. The company ended the quarter with $25.3M cash, $7.4M of finance-lease debt and an undrawn ABL borrowing base of $19.4M.

Management cited contributions from the ResMetrics acquisition (late July 2025), stronger U.S. and international sales, a 19% decline in Canadian revenue, improved nine-month cash from operations and a favourable appellate ruling in an October 2025 patent matter.

NCS Multistage Holdings (NASDAQ:NCSM) will release its third quarter 2025 earnings the evening of Oct 29, 2025 and host a conference call on Oct 30, 2025 at 7:30 a.m. CT (8:30 a.m. ET) to discuss results.

The call will be available via live audio webcast; participants who wish to ask questions must register to receive dial-in numbers and a unique PIN, while others may join a listen-only webcast. Attendees are recommended to join at least 10 minutes early. A replay will be posted in the Investors section of the company website shortly after the call and will remain available for approximately seven days.

Company profile: NCS provides engineered products and services for onshore and offshore oil and natural gas well construction and completions across North America and selected international markets. Contact: Mike Morrison, CFO and Treasurer, +1 281-453-2222, IR@ncsmultistage.com.

NCS Multistage Holdings (NASDAQ:NCSM), a leading provider of engineered products for oil and natural gas well optimization, announced its participation in three upcoming investor conferences in August 2025.

CEO Ryan Hummer will present at the EnerCom Denver Conference in-person on August 19, followed by virtual presentations at the Sidoti Investor Conference and Emerging Growth Conference on August 21. The Sidoti event will also include one-on-one investor meetings.

Webcasts of the presentations will be available on the company's website for approximately 90 days after the events.

NCS Multistage Holdings (NASDAQ: NCSM) reported strong Q2 2025 performance with total revenues of $36.5M, marking a 22.8% year-over-year increase. The growth was primarily driven by increased fracturing systems activity and frac plug sales in the U.S. and Canada.

The company's U.S. operations showed significant improvement with a 45% sequential revenue increase, while international revenues grew 67.2% sequentially. However, adjusted gross margins declined to 35.7% from 40.3% in Q2 2024. Notable achievements include $2.2M in Adjusted EBITDA and the completion of the ResMetrics acquisition, expected to contribute $4-5M in revenue and $1-1.5M in EBITDA in FY25.

NCS Multistage Holdings (NASDAQ:NCSM) reported strong Q2 2025 financial results with total revenues of $36.5 million, marking a 23% year-over-year increase. The company achieved net income of $0.9 million and diluted EPS of $0.34, including a $1.4 million benefit from a Canadian tax valuation allowance release.

Key financial metrics include Adjusted EBITDA of $2.2 million, a $1.3 million improvement year-over-year, with $25.4 million in cash and $7.7 million in total debt as of June 30, 2025. The company maintains strong liquidity with over $17 million available in an undrawn credit facility.

Notably, NCSM announced the acquisition of Reservoir Metrics (ResMetrics) for $5.9 million plus potential earn-outs, expanding its tracer diagnostics capabilities. ResMetrics generated over $10 million in trailing twelve-month revenue with a 30%+ EBITDA margin.

NCS Multistage Holdings (NASDAQ:NCSM) has announced the acquisition of ResMetrics LLC, a leading provider of chemical tracer diagnostics services for the oil and gas industry. The strategic acquisition enhances NCS's tracer diagnostics capabilities and expands their service offering for well optimization and reservoir development.

ResMetrics specializes in chemical tracer technologies that help operators validate reservoir strategies, improve fracture designs, evaluate well connectivity, and optimize oil recovery programs. The company operates primarily in the United States, UAE, and Kuwait. The acquisition details will be discussed during NCS's Q2 earnings call on August 1, 2025.

NCS Multistage Holdings (NASDAQ:NCSM), a leading provider of engineered products for oil and natural gas well optimization, has scheduled its Q2 2025 earnings conference call for August 1, 2025 at 7:30 AM Central Time. The company will release its earnings report the evening before the call.

NCS provides specialized products and services for well construction and field development, primarily serving exploration and production companies in North America and international markets including the North Sea, Middle East, Argentina, and China. Their solutions are utilized in both onshore and offshore wells with horizontal laterals in unconventional and conventional formations.

NCS Multistage Holdings (NASDAQ:NCSM), a leading provider of engineered products for oil and natural gas well optimization, announced that CEO Ryan Hummer will present at the Emerging Growth Conference on May 21, 2025 at 1:55 PM CT. The presentation will be available for approximately 90 days on the company's website.

NCS specializes in products and services for onshore and offshore wells with horizontal laterals in both unconventional and conventional oil and gas formations. The company serves exploration and production companies across North America and international markets including the North Sea, Middle East, Argentina, and China.

NCS Multistage Holdings (NASDAQ: NCSM) reported strong financial results for Q1 2025, with total revenues reaching $50.0M, marking a 14% year-over-year increase and the highest quarterly revenue since Q1 2020. The company saw significant growth in Canadian operations and services revenue across all regions, though U.S. product sales declined due to project delays. Canadian activity was particularly strong in fracturing system completions, while international revenue benefited from tracer diagnostics work in the Middle East and sales in the North Sea. Gross margins improved from 40.1% to 43.7% year-over-year. The company's liquidity position strengthened to $49.8M, up from $34.4M in Q1 2024, and Adjusted EBITDA reached $8.2M, a $2.1M improvement year-over-year.